Instil Bio, Inc. — Director's Dealing 2022

May 3, 2022

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Instil Bio, Inc. (TIL)
CIK: 0001789769
Period of Report: 2022-05-03

Reporting Person: Ray Sumita (Chief Legal and Admin Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Employee Stock Option (right to buy)	$8.4	2032-04-22	Common Stock (425000.0)		Direct

Footnotes

F1: Twenty-five percent (25%) of the shares subject to the option vest on April 18, 2023, and the remaining shares subject to the option vested or shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.